Investing.com - Amarin reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amarin announced earnings per share of $0.03 on revenue of $154.5M. Analysts polled by Investing.com anticipated EPS of $-0.0313 on revenue of $153.09M.
Amarin shares are up 22% from the beginning of the year and are trading at $4.440 , down-from-52-week-high.They are outperforming the S&P 500 which is up 17.22% from the start of the year.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar